125 related articles for article (PubMed ID: 22980919)
1. Protein anticoagulants targeting factor VIIa-tissue factor complex: a comprehensive review.
Shah K; Bayoumi R; Banerjee Y
Hematology; 2013 Jan; 18(1):1-7. PubMed ID: 22980919
[TBL] [Abstract][Full Text] [Related]
2. Hemextin AB complex, a unique anticoagulant protein complex from Hemachatus haemachatus (African Ringhals cobra) venom that inhibits clot initiation and factor VIIa activity.
Banerjee Y; Mizuguchi J; Iwanaga S; Kini RM
J Biol Chem; 2005 Dec; 280(52):42601-11. PubMed ID: 16204244
[TBL] [Abstract][Full Text] [Related]
3. Modulators of the coagulation cascade: focus and recent advances in inhibitors of tissue factor, factor VIIa and their complex.
Frédérick R; Pochet L; Charlier C; Masereel B
Curr Med Chem; 2005; 12(4):397-417. PubMed ID: 15720249
[TBL] [Abstract][Full Text] [Related]
4. A single-domain antibody that blocks factor VIIa activity in the absence but not presence of tissue factor.
Ferrière S; Kawecki C; Ottavi JF; Denis CV; Kauskot A; Christophe OD; Lenting PJ
J Thromb Haemost; 2019 Dec; 17(12):2035-2046. PubMed ID: 31423724
[TBL] [Abstract][Full Text] [Related]
5. Inhibitors of Factor VIIa/tissue factor.
Shirk RA; Vlasuk GP
Arterioscler Thromb Vasc Biol; 2007 Sep; 27(9):1895-900. PubMed ID: 17600222
[TBL] [Abstract][Full Text] [Related]
6. Polycations selectively blocking tissue factor-dependent FVII activation: collective in vitro anticoagulation studies.
Chu AJ
Inflamm Allergy Drug Targets; 2011 Feb; 10(1):13-8. PubMed ID: 21184651
[TBL] [Abstract][Full Text] [Related]
7. Protease nexin-2/Amyloid beta-protein precursor regulates factor VIIa and the factor VIIa-tissue factor complex.
Mahdi F; Rehemtulla A; Van Nostrand WE; Bajaj SP; Schmaier AH
Thromb Res; 2000 Aug; 99(3):267-76. PubMed ID: 10942793
[TBL] [Abstract][Full Text] [Related]
8. Transition state analysis of the complex between coagulation factor VIIa and tissue factor: suggesting a sequential domain-binding pathway.
Osterlund M; Persson E; Svensson M; Carlsson U; Freskgård PO
Biochem Biophys Res Commun; 2005 Feb; 327(3):789-93. PubMed ID: 15649415
[TBL] [Abstract][Full Text] [Related]
9. Large enhancement of functional activity of active site-inhibited factor VIIa due to protein dimerization: insights into mechanism of assembly/disassembly from tissue factor.
Stone MD; Harvey SB; Martinez MB; Bach RR; Nelsestuen GL
Biochemistry; 2005 Apr; 44(16):6321-30. PubMed ID: 15835921
[TBL] [Abstract][Full Text] [Related]
10. The epidermal growth factor receptor (EGFR) and proline rich tyrosine kinase 2 (PYK2) are involved in tissue factor dependent factor VIIa signalling in HaCaT cells.
Wiiger MT; Prydz H
Thromb Haemost; 2004 Jul; 92(1):13-22. PubMed ID: 15213840
[TBL] [Abstract][Full Text] [Related]
11. Hemextin AB complex--a snake venom anticoagulant protein complex that inhibits factor VIIa activity.
Banerjee Y; Mizuguchi J; Iwanaga S; Kini RM
Pathophysiol Haemost Thromb; 2005; 34(4-5):184-7. PubMed ID: 16707924
[TBL] [Abstract][Full Text] [Related]
12. Local activation of the tissue factor-factor VIIa pathway in patients with pneumonia and the effect of inhibition of this pathway in murine pneumococcal pneumonia.
Rijneveld AW; Weijer S; Bresser P; Florquin S; Vlasuk GP; Rote WE; Spek CA; Reitsma PH; van der Zee JS; Levi M; van der Poll T
Crit Care Med; 2006 Jun; 34(6):1725-30. PubMed ID: 16625114
[TBL] [Abstract][Full Text] [Related]
13. Allosteric activation of coagulation factor VIIa.
Persson E; Olsen OH
Front Biosci (Landmark Ed); 2011 Jun; 16(8):3156-63. PubMed ID: 21622226
[TBL] [Abstract][Full Text] [Related]
14. Sequential coagulation factor VIIa domain binding to tissue factor.
Osterlund M; Persson E; Carlsson U; Freskgård PO; Svensson M
Biochem Biophys Res Commun; 2005 Dec; 337(4):1276-82. PubMed ID: 16236263
[TBL] [Abstract][Full Text] [Related]
15. Enhancing the anticoagulant potency of soluble tissue factor mutants by increasing their affinity to factor VIIa.
Yang J; Lee GF; Riederer MA; Kelley RF
Thromb Haemost; 2002 Mar; 87(3):450-8. PubMed ID: 11916078
[TBL] [Abstract][Full Text] [Related]
16. Tissue Factor-Factor VIIa complex induces cytokine expression in coronary artery smooth muscle cells.
Demetz G; Seitz I; Stein A; Steppich B; Groha P; Brandl R; Schömig A; Ott I
Atherosclerosis; 2010 Oct; 212(2):466-71. PubMed ID: 20708733
[TBL] [Abstract][Full Text] [Related]
17. The tissue factor/factor VIIa/factor Xa complex: a model built by docking and site-directed mutagenesis.
Norledge BV; Petrovan RJ; Ruf W; Olson AJ
Proteins; 2003 Nov; 53(3):640-8. PubMed ID: 14579355
[TBL] [Abstract][Full Text] [Related]
18. Influence of warfarin therapy on activated factor VII clotting activity.
Lippi G; Montagnana M; Salvagno GL; Poli G; Franchini M; Guidi GC
Blood Coagul Fibrinolysis; 2006 Apr; 17(3):221-4. PubMed ID: 16575262
[TBL] [Abstract][Full Text] [Related]
19. A soluble tissue factor mutant is a selective anticoagulant and antithrombotic agent.
Kelley RF; Refino CJ; O'Connell MP; Modi N; Sehl P; Lowe D; Pater C; Bunting S
Blood; 1997 May; 89(9):3219-27. PubMed ID: 9129026
[TBL] [Abstract][Full Text] [Related]
20. Tissue factor pathway inhibitor inhibits aortic smooth muscle cell migration induced by tissue factor/factor VIIa complex.
Sato Y; Asada Y; Marutsuka K; Hatakeyama K; Kamikubo Y; Sumiyoshi A
Thromb Haemost; 1997 Sep; 78(3):1138-41. PubMed ID: 9308767
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]